Biopsy Devices Market Dynamics, Competitive Landscape, Opportunities and Forecast to 2030
Biopsy Devices Market
Overview
A Biopsy is performed
to obtain a piece of tissue or a sample of cells from a patient’s body. Biopsy
devices such as Biopsy Needles, biopsy needles, forceps, biopsy guidance
system, and others are used for the same. The Global Biopsy Devices Market . is
anticipated to scale to a valuation of USD 2.4 Bn at a CAGR of 6.80% by the end
of the forecast period of 2022-2030, as per a recent study by Market Research
Future (MRFR).
A biopsy is carried
out to diagnose any inflammatory conditions, infestations diseases, in case of
organ transplantation, and for the evaluation of fertility. However, biopsy has
gained traction in the cancer arena. A biopsy is the only definitive way to
determine the presence of cancer. Oncology diseases are spreading at an
alarming rate which has generated massive demand for screening. There is a huge
demand for high-quality diagnostic processes, especially huge unmet needs in
the emerging economies of the world create a conducive environment for the
growth of the global Biopsy Devices Market.
Minimally invasive
biopsies have replaced open surgical excisional biopsy in patients which has
not only reduced costs but also reduced the psychological burden affecting
patients. This has encouraged patients to undergo biopsy procedures and in
turn, induced demand within the global biopsy devices market. Furthermore,
technological advancement in biopsy devices has led to the development of
improved and automated biopsy devices which can even be used with greater ease
and less expertise. Also, safety quotient is also increased in automated biopsy
devices.
Market Segmentation
The Global Biopsy
Devices Market has been segmented based on product type, application, and end
user.
By product type, the
global biopsy devices market has been segmented into biopsy guns, biopsy
guidance system, biopsy needles, forceps, and others.
By application, the
market has been segmented into bone marrow biopsy, surgical biopsy, skin
biopsy, needle biopsy, Cancer Diagnosis, and others.
By end user, market
has been segmented into hospitals, specialty clinics, diagnostic centers,
academic & research institutes, and others.
Regional
Analysis
North America biopsy
devices market is expected to hold the grand share of the global market. Europe
market can secure the second position globally. Asia Pacific market can surge
at a high pace. The availability of firm medical infrastructure can bolster the
expansion of the biopsy device market across the study period. Hectic work-life
schedule, consumption of poor diet, genetics, and environmental factors are
chief cause for the high prevalence of cancer in the region. These are creating
several growth opportunities for the expansion of the regional market. Europe
boasting of the easy availability of experts that can handle biopsy devices can
prompt the expansion of the regional market in near future. Expansion of ageing
populace and high prevalence of cancer in APAC can support the growth of the
market across the assessment period.
Competitive
Landscape
Global Biopsy Devices Market Players include Focal Therapeutics,
Inc., C. R. Bard, Inc. Creganna, Scion Medical Technologies, LLC. (UK), BD,
Integra LifeSciences Corporation, Hologic, Inc., Argon Medical Devices, Inc.,
Precision Biopsy, LLC, Cook Medical, and Leica Biosystems.
About
Market Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact
us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th
Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
.jpg)
Comments
Post a Comment